These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


577 related items for PubMed ID: 27001906

  • 1. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
    Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW, Yun YH, Jung Y.
    Nat Commun; 2016 Mar 22; 7():10993. PubMed ID: 27001906
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y, Zhang J.
    J Pathol; 2014 Sep 22; 234(1):46-59. PubMed ID: 24817606
    [Abstract] [Full Text] [Related]

  • 3. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F, Fan X, Chen B, Dong P, Zheng J.
    Cell Physiol Biochem; 2016 Sep 22; 39(6):2409-2420. PubMed ID: 27832641
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
    Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M, Men R, Li P, Dong B, Liu L, Fu X, Xu H, Aqeilan RI, Wei YQ, Yang L, Peng Y.
    Cell Death Dis; 2018 Jun 18; 9(7):718. PubMed ID: 29915227
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened.
    Lu CH, Hou QR, Deng LF, Fei C, Xu WP, Zhang Q, Wu KM, Ning BF, Xie WF, Zhang X.
    Dig Dis Sci; 2015 Jul 18; 60(7):2038-48. PubMed ID: 25686745
    [Abstract] [Full Text] [Related]

  • 6. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F, Yang J, Huang K, Pan X, Chen B, Dong P, Zheng J.
    Cell Physiol Biochem; 2016 Jul 18; 40(1-2):183-194. PubMed ID: 27855367
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.
    Zhu J, Zhang Z, Zhang Y, Li W, Zheng W, Yu J, Wang B, Chen L, Zhuo Q, Chen L, Zhang J, Liu J.
    Biochem Biophys Res Commun; 2018 Jan 29; 496(1):176-183. PubMed ID: 29307832
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J, Yu Y, Li S, Liu Y, Zhou S, Cao S, Yin J, Li G.
    J Cell Mol Med; 2017 Dec 29; 21(12):3679-3692. PubMed ID: 28766848
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
    Sun J, Zhang H, Li L, Yu L, Fu L.
    Oncol Rep; 2017 Mar 29; 37(3):1698-1706. PubMed ID: 28098912
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J, Wang W, Yu F, Dong P, Chen B, Zhou MT.
    Cell Physiol Biochem; 2018 Mar 29; 46(1):82-92. PubMed ID: 29587268
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-361 suppresses the biological processes of hepatic stellate cells in HBV-relative hepatic fibrosis by NF-kappaB p65.
    Yu G, Mu H, Zhou H, Fang F, Cui Y, Wu Q, Xiong Q, Li H.
    Cells Dev; 2021 Sep 29; 167():203711. PubMed ID: 34216805
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
    Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N.
    Gut; 2012 Nov 29; 61(11):1600-9. PubMed ID: 22267590
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
    Lu L, Wang J, Lu H, Zhang G, Liu Y, Wang J, Zhang Y, Shang H, Ji H, Chen X, Duan Y, Li Y.
    Biochem Biophys Res Commun; 2015 Sep 25; 465(3):387-93. PubMed ID: 26255201
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
    Li F, Ma N, Zhao R, Wu G, Zhang Y, Qiao Y, Han D, Xu Y, Xiang Y, Yan B, Jin J, Lv G, Wang L, Xu C, Gao X, Luo S.
    J Cell Mol Med; 2014 Jun 25; 18(6):966-74. PubMed ID: 24801603
    [Abstract] [Full Text] [Related]

  • 15. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.
    Ji F, Wang K, Zhang Y, Mao XL, Huang Q, Wang J, Ye L, Li Y.
    J Cell Biochem; 2019 Mar 25; 120(3):4573-4581. PubMed ID: 30368874
    [Abstract] [Full Text] [Related]

  • 16. Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells.
    Chen X, Zhang D, Wang Y, Chen K, Zhao L, Xu Y, Jiang H, Wang S.
    Cell Death Dis; 2020 May 28; 11(5):402. PubMed ID: 32467578
    [Abstract] [Full Text] [Related]

  • 17. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
    Kim J, Lee C, Shin Y, Wang S, Han J, Kim M, Kim JM, Shin SC, Lee BJ, Kim TJ, Jung Y.
    Mol Ther; 2021 Apr 07; 29(4):1471-1486. PubMed ID: 33348053
    [Abstract] [Full Text] [Related]

  • 18. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
    Du J, Niu X, Wang Y, Kong L, Wang R, Zhang Y, Zhao S, Nan Y.
    Sci Rep; 2015 Nov 05; 5():16163. PubMed ID: 26537990
    [Abstract] [Full Text] [Related]

  • 19. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
    Yang X, Ma L, Wei R, Ye T, Zhou J, Wen M, Men R, Aqeilan RI, Peng Y, Yang L.
    Signal Transduct Target Ther; 2020 Jun 05; 5(1):75. PubMed ID: 32499481
    [Abstract] [Full Text] [Related]

  • 20. Leptin up-regulates microRNA-27a/b-3p level in hepatic stellate cells.
    Li Z, Ji L, Su S, Zhu X, Cheng F, Jia X, Zhou Q, Zhou Y.
    Exp Cell Res; 2018 May 01; 366(1):63-70. PubMed ID: 29548749
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.